Your session is about to expire
← Back to Search
Inhaled Steroids/Long-Acting Bronchodilators for Asthma
Study Summary
This trial is looking at the different sites and causes of airflow limitation in asthmatics, and whether certain treatments can help.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 10 and 80 years old.My lung function tests show severe asthma or COPD.My asthma is under control with treatment.I currently do not smoke and have smoked less than 10 pack-years.
- Group 1: Asthma observational study arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical issues does this therapy commonly address?
"This medication can help alleviate allergies to mold, as well as sinusitis, vasomotor rhinitis, and acute coryza."
Is this therapy considered to be risk-free for those who are treated?
"This treatment has demonstrated sufficient safety and efficacy, receiving a score of 3 on our scale. This is because the drug is in Phase 4 clinical trials, meaning it is approved for use."
What is the uppermost capacity for enrollment into this exploration?
"Affirmative. The information on clinicaltrials.gov affirms that this research project, which was first published on October 1st 2007, is actively enrolling individuals. A total of 50 participants must be recruited from a single site."
Is enrollment open at this time for the clinical trial?
"According to clinicaltrials.gov, this medical trial is actively searching for volunteers and has been doing so since October 1st 2007 when it was first posted; the most recent update being on July 26th 2020."
Is the eligibility for this research limited to those below 30 years of age?
"As stipulated by the research protocol, prospective participants need to be between 10 and 80 years old."
Are there any other studies demonstrating the effectiveness of this treatment method?
"Presently, there are 48 trials investigating the efficacy of this treatment. Of those active clinical studies, 16 have progressed to Phase 3. Research sites for this particular medication are mainly based in Ann Arbor but span 1291 locations globally."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger